Volume 76, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Vietnam is participating in a global de-worming effort that aims to treat 650 million school children regularly by 2010. The treatment used in Vietnam is single dose oral mebendazole (Phardazone®) 500 mg. We tested the efficacy of single dose mebendazole 500 mg in the therapy of hookworm infection in a randomized double-blind placebo-controlled trial among 271 Vietnamese schoolchildren. The treatment efficacy of single dose mebendazole in children did not differ significantly from placebo, with a reduction in mean eggs per gram of feces relative to placebo of 31% (95% CI -9 to 56%, = 0.1). In light of these findings we then carried out a similar randomized trial comparing triple dose mebendazole, single dose albendazole, and triple dose albendazole against placebo in 209 adults in the same area. The estimated reduction in mean post-treatment eggs per gram of feces relative to placebo was 63% (95% CI 30–81%) for triple mebendazole, 75% (47–88%) for single albendazole, and 88% (58–97%) for triple albendazole. Our results suggest that single dose oral mebendazole has low efficacy against hookworm infection in Vietnam, and that it should be replaced by albendazole. These findings are of major public health relevance given the opportunity costs of treating entire populations with ineffective therapies. We recommend that efficacy of anti-helminth therapies is pilot tested before implementation of national gut worm control programs.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Technical Report Series No. 912, WHO, Geneva.
  2. De Silva NR, 2003. Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes. Acta Trop 86 : 197–214. [Google Scholar]
  3. Crompton DWT, Nesheim MC, 2002. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr 22 : 35–59. [Google Scholar]
  4. Awasthi S, Bundy DAP, Savioli L, 2003. Helminthic infections. BMJ 327 : 431–433. [Google Scholar]
  5. De Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L, 2003. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 19 : 547–551. [Google Scholar]
  6. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao SH, 2004. Hookworm infection. N Engl J Med 351 : 799–807. [Google Scholar]
  7. Brooker S, Bethony J, Hotez PJ, 2004. Human hookworm infection in the 21st century. Adv Parasitol 58 : 197–288. [Google Scholar]
  8. Human helminth infections in Southeast Asia. Report UNICEF East Asia and Pacific Region Office. Bangkok, Thailand, July 2002.
  9. Personal communication with Dr Antonio Montresor, Public Health Specialist Vectorborne and other Parasitic Diseases. WHO Hanoi, December 30, 2005.
  10. WHO Western Pacific. Over 55 million people in Viet Nam infected with intestinal worms. Press release, December 2005.
  11. Flohr C, Tuyen LN, Lewis S, Quinnell RJ, Minh TT, Liem HT, Campbell J, Pritchard DI, Hien TT, Farrar J, Williams H, Britton J, 2006. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: a cross-sectional study. J Allergy Clin Immunol. 118 : 1305–1311. [Google Scholar]
  12. Coles GC, Bauer C, Borgsteede FHM, Geerts S, Klei TR, Taylor MA, Waller PJ, 1992. World Association for the Advancement of Veterinary Parasitology (WAAVP) methods for the detection of anthelminthic resistance in nematodes of veterinary importance. Vet Parasitol 44 : 35–44. [Google Scholar]
  13. Bennett A, Guyatt H, 2000. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today 16 : 71–74. [Google Scholar]
  14. Horton J, 2000. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 121 : S113–S132. [Google Scholar]
  15. Hall A, 1981. Quantitative variability of nematode egg counts in faeces: a study among rural Kenyans. Trans R Soc Trop Med Hyg 75 : 682–687. [Google Scholar]
  16. De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, Vercruysse J, 1997. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 57 : 25–30. [Google Scholar]
  17. Sacko M, De Clerq D, Behnke JM, Gilbert FS, Dorny P, Vercruysse J, 1999. Comparison of the efficacy of mebendazole, albendazole and pyrantel in treatment of human hookworm infections in the southern region of Mali, West Africa. Trans R Soc Trop Med Hyg 93 : 195–203. [Google Scholar]
  18. Dacombe RJ, Crampin AC, Floyd S, Randall A, Ndhlovu R, Bickle Q, Fine PEM, 2007. Time delays between patient and laboratory selectively affect accuracy of helminth diagnosis. Trans R Soc Trop Med Hyg 101 : 140–145. [Google Scholar]
  19. Raso G, Vounatsou P, Gosoniu L, Tanner M, N’Goran EK, Utzinger J, 2006. Risk factors and spatial patterns of hookworm infection among schoolchildren in a rural area of western Cote d’Ivoire. Int J Parasitol 5 : 201–210. [Google Scholar]
  20. Wesche D, Barnish G, 1994. A comparative study of the effectiveness of mebendazole (Janssen) and generically equivalent mebendazole (Nordia) in intestinal helminthiasis in Papua New Guinean children. P N G Med J 37 : 7–11. [Google Scholar]
  21. Albonico M, Smith PG, Hall A, Chwaya HM, Alawi KS, Savioli L, 1994. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans R Soc Trop Med Hyg 88 : 585–589. [Google Scholar]
  22. Hall A, Nahar Q, 1994. Albendazole and infections with Ascaris lumbricoides and Trichuris trichiura in children in Bangladesh. Trans R Soc Trop Med Hyg 88 : 110–112. [Google Scholar]
  23. Waller PJ, 1990. Resistance in nematode parasites of livestock to the benzimidazole anthelmintics. Parasitol Today 6 : 127–129. [Google Scholar]
  24. Albonico M, Engels D, Savioli L, 2004. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int J Parasitol 34 : 1205–1210. [Google Scholar]
  25. Albonico M, Bickle Q, Ramsan M, Montresor A, Savioli L, Taylor M, 2003. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 81 : 343–352. [Google Scholar]
  26. Geerts S, Gryseels B, 2000. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev 13 : 207–222. [Google Scholar]
  27. Longfils P, Heang UK, Soeng H, Sinuon M, 2005. Weekly iron and folic acid supplementation as a tool to reduce anemia among primary school children in Cambodia. Nutr Rev 63 : S139–S145. [Google Scholar]
  28. Albonico M, Wright V, Ramsan M, Haji HJ, Taylor M, Savioli L, Bickle Q, 2005. Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int J Parasitol 35 : 803–811. [Google Scholar]
  29. Albonico M, Wright V, Bickle Q, 2004. Molecular analysis of the β-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasitol 134 : 281–284. [Google Scholar]
  30. Montresor A, Crompton DWT, Gyorkos TW, Savioli L, 2002. Helminth control in school-age children. A guide for managers of control programmes. WHO, Geneva.
  31. Utzinger J, Keiser J, 2004. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5 : 263–285. [Google Scholar]
  32. Xiao SH, Wu HM, Tanner M, Utzinger J, Wang C, 2005. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94 : 1–14. [Google Scholar]
  33. Hotez PJ, Zhan B, Bethony JM, Loukas A, Williamson A, Goud G, Hawdon JM, Dobardzic A, Dobardzic R, Ghosh K, Bottazzi ME, Mendez S, Zook B, Wang Y, Liu S, Essiet-Gibson I, Chung-Debose S, Xiao SH, Knox D, Meagher M, Inan M, Correa-Oliveira R, Vilk P, Shepherd HR, Brandt W, Russell PK, 2003. Progress in the development of a recombinant vaccine for human hookworm disease: The Human Hookworm Vaccine Initiative. Int J Parasitol 33 : 1245–1258. [Google Scholar]

Data & Media loading...

  • Received : 25 Apr 2006
  • Accepted : 22 Nov 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error